Loading…
Bioaccumulation Potential of 4‘‘-epi-(Methylamino)-4‘‘-deoxyavermectin B1a Benzoate (Emamectin Benzoate) in Bluegill Sunfish
Rapid uptake of [5-3H]MAB1a by bluegill was observed under flow-through aqueous conditions, attaining steady-state concentration by about 21 and 10 days, respectively, in whole fish and viscera. Uptake by fillet was, by comparison, much lower, and steady state was not attained by 28 days. Residue le...
Saved in:
Published in: | Journal of agricultural and food chemistry 1996-09, Vol.44 (9), p.2894-2899 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Rapid uptake of [5-3H]MAB1a by bluegill was observed under flow-through aqueous conditions, attaining steady-state concentration by about 21 and 10 days, respectively, in whole fish and viscera. Uptake by fillet was, by comparison, much lower, and steady state was not attained by 28 days. Residue levels on the final exposure day (i.e., day 28) were 90, 40, and 128 μg/kg, respectively, in whole fish, fillet, and viscera. Following 14 days of depuration, these residue levels all declined by about 90%. The steady-state bioconcentration factors for whole fish, fillet, and viscera were 80, 30, and 116, respectively, indicating that emamectin benzoate will neither bioconcentrate in individual aquatic organisms nor biomagnify in the food chain. Analysis of 28-day-exposed fish by HPLC showed that the only significant metabolite was the N-demethylated derivative, comprising about 14% and 9%, respectively, of total residues in fillet and viscera, while parent emamectin benzoate was about 63% and 49%, respectively. Keywords: Avermectin; bioaccumulation; bioconcentration; HPLC; biomagnification; bluegill sunfish; emamectin benzoate; metabolism |
---|---|
ISSN: | 0021-8561 1520-5118 |
DOI: | 10.1021/jf960228z |